105,000 common shares proposed for sale by ORKA (NASDAQ: ORKA)

Rhea-AI Filing Summary

ORKA-related securities holder submitted a Form 144 proposing sales of common stock totaling 105,000 shares. The filing lists two transactions: 62,260 shares tied to an Exercise of Stock Options dated 05/21/2026 and 42,740 shares from a Partnership Distribution dated 02/14/2024. The sales are described as cash transactions.

Insights

Securities Attorney

Form 144 notifies intent to sell 105,000 common shares via option exercise and partnership distribution.

The filing lists 62,260 shares from an Exercise of Stock Options (05/21/2026) and 42,740 shares from a Partnership Distribution (02/14/2024). It records cash as the transaction consideration.

These disclosures are procedural notices under resale rules; the listed methods and dates are the primary verifiable items. Subsequent trade reports will show whether the proposed sales were executed and their execution details.

Key Figures

Total proposed sale: 105,000 shares Option exercise shares: 62,260 shares Partnership distribution shares: 42,740 shares +1 more

4 metrics

Total proposed sale 105,000 shares aggregate line in filing

Option exercise shares 62,260 shares Exercise of Stock Options dated <date>05/21/2026</date>

Partnership distribution shares 42,740 shares Partnership Distribution dated <date>02/14/2024</date>

Aggregate dollar figure (as filed) $6,370,350.00 numeric field on filing cover line

Key Terms

Form 144, Exercise of Stock Options, Partnership Distribution

3 terms

Form 144 regulatory

"Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Exercise of Stock Options financial

"Common | 05/21/2026 | Exercise of Stock Options"

Partnership Distribution financial

"Common | 02/14/2024 | Partnership Distribution"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	105000	6370350.00	60312101	05/21/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/21/2026	Exercise of Stock Options	Issuer			62260	05/21/2026	Cash
Common	02/14/2024	Partnership Distribution	Issuer			42740	02/14/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does ORKA's Form 144 disclose about shares offered for sale?

It discloses a proposed resale of 105,000 common shares in total. The filing specifies 62,260 shares from an option exercise (05/21/2026) and 42,740 shares from a partnership distribution (02/14/2024).

Who is the recipient of proceeds and what is the payment method in the Form 144?

The filing indicates the transactions are described as cash transactions. It lists the form of consideration as cash for both the option exercise and the partnership distribution dated in the filing.

Do the Form 144 entries show execution dates for the proposed sales?

Yes. The exercise-based sale is dated 05/21/2026 and the partnership distribution sale is dated 02/14/2024. Those dates are provided in the filing as the transaction dates.

How are the two share lots in the Form 144 categorized?

The filing categorizes one lot as an Exercise of Stock Options (62,260 shares) and the other as a Partnership Distribution (42,740 shares), with both recorded under common stock for resale.